Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-022871
Filing Date
2017-04-11
Accepted
2017-04-11 16:02:43
Documents
1
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3828
  Complete submission text file 0001104659-17-022871.txt   5065
Mailing Address
Business Address
HOWSON TAMAR D (Reporting) CIK: 0001202286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 17755989

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations